eClinical Tech News

Sanofi Bolsters Rare Disease Portfolio and Immunology Presence with Blueprint Medicines Acquisition Sanofi has finalized its acquisition of Blueprint...

Hookipa Pharma’s planned delisting from Nasdaq and subsequent dissolution signal the final chapter in the company’s independent journey. Following...

Merck’s Springworks Therapeutics secures landmark approval from the European Commission for Ezmekly (mirdametinib) for treating symptomatic, inoperable plexiform neurofibromas...

The European Commission has granted conditional marketing authorization to Springworks Therapeutics’ Ezmekly (mirdametinib) for treating symptomatic, inoperable plexiform neurofibromas...

Longevity Health Holdings (Nasdaq: XAGE), a company focused on longevity and healthy aging, is merging with True Health Inc....

Branded Legacy Inc. is undergoing a rapid transformation, shifting its focus from plant-based wellness and cannabis beverages to the...

Ttam Research Institute, a non-profit led by Anne Wojcicki, has finalized its acquisition of 23andMe’s personal genome service and...

Salarius Pharmaceuticals has received another extension from Nasdaq, pushing the deadline for regaining compliance with minimum bid price and...

Iovance Biotherapeutics’ real-world data reinforces the clinical value of Lifileucel (amtagvi) in advanced melanoma. The recently released data from...

Rakovina Therapeutics’ partner, Variational AI, has been awarded the 2025 Emerging Company of the Year – Biotech by Life...